Nestlé has issued its largest-ever recall of infant formula after discovering traces of a potent toxin known as cereulide in an ingredient used in its products. The Swiss multinational said the contaminant was found in arachidonic acid oil, a controversial additive used in some formulas to support brain development and immune function. Cereulide is a rare but dangerous toxin that attacks cell mitochondria, leading to cell death and triggering severe nausea and vomiting as the body attempts to expel the poison. Nestlé’s recall spans roughly 50 countries and includes products from Nestlé SA, Danone SA, and Groupe Lactalis.
The recall has revived long-simmering questions about infant formula safety and corporate accountability. Arachidonic acid oil itself is a subject of debate: while marketed as beneficial for infant growth, it has been linked in some research to inflammation, heart disease, metabolic disorders, and even cancer and neurodegenerative conditions. Its use in formula is not mandated by any regulatory body, which raises concerns about whether such additives are necessary or safe for widespread infant consumption. Nestlé’s announcement comes amid an ongoing global conversation about the transparency and regulation of ingredients in products intended for the most vulnerable consumers.
Nestlé’s latest crisis is not an isolated incident. The company has repeatedly faced scrutiny over the safety of its baby foods and formula products. Between 2021 and 2025, Gerber—owned by Nestlé—was found to contain concerning levels of heavy metals including lead and arsenic. These toxins are known to impair brain development and have been linked to lifelong learning disabilities, stunted growth, lower IQ, anemia, cancer, and heart disease. In 2008, traces of the industrial chemical melamine were detected in Nestlé milk products in Asia, triggering widespread alarm and regulatory action.
The company’s record also includes a long-criticized history of aggressive marketing of infant formula in developing countries during the 1970s and 1980s. Nestlé promoted formula as a superior alternative to breast milk at a time when many families lacked access to clean water, leading to widespread infant illness and deaths. A 2018 study published by the National Bureau of Economic Research estimated a 27% increase in infant mortality—about 212,000 deaths per year—at the peak of Nestlé’s marketing campaigns. Critics argue that the latest recall highlights a pattern of corporate behavior that places profits over infant safety and public health.
Despite repeated scandals, Nestlé remains one of the world’s most profitable companies. Bloomberg estimates that the recall represents less than 0.5% of Nestlé’s global sales, suggesting the financial impact may be limited. Still, analysts warn of potential reputational damage, especially in a market where trust is paramount. Yet, as Nestlé’s history suggests, controversies have not significantly weakened the company’s global dominance. Past allegations include child slavery in cocoa production, extensive water extraction in California, and even historical ties to Nazi financing and supply contracts during World War II—issues that have repeatedly sparked public outrage without substantially denting Nestlé’s commercial strength.
The latest recall may therefore test whether sustained scrutiny and public backlash can finally shift the balance of power between global corporations and consumer safety, or whether Nestlé will once again weather the storm with minimal long-term consequences.
